With our technology, patients whose files need to be reviewed in priority are automatically identified by an alert score. The higher the score, the more important it is to review the file, because the chances of success of an intervention are that much higher. Rather than reviewing all 200 patients who receive antibiotics, the pharmacist looks at around forty, using a strategy supported by software that gathers all the information required for a good review of the file.
– Vincent Nault, President, LUMED

LUMED, a software development company dedicated to improving hospital care, was born in Sherbrooke in 2012. It started a few years earlier as part of a research project on the optimal use of antibiotics to treat infectious diseases, particularly by avoiding their overuse.

The wide range of medical and computer skills of the three founders Louis Valiquette, Mathieu Beaudoin and Vincent Nault, has led to the design of the world’s most effective antibiotic stewardship system: the subject of various publications, widely recognized by pharmacists and infectious disease specialists, and winner of several awards for innovation.

The company’s flagship software, APSS, tracks the progress of hospitalized patients over time and identifies potential improvements to their treatments. The positive impacts of this software affect both patients and hospital administration, as well as the use of resources involved in the treatment process.

To develop and commercialize its software, LUMED has benefited from the support of various provincial research funds, such as the NSERC, FRQS, MEDTEQ, Canada Economic Development and the Business Development Bank of Canada. The company was also chosen by Université de Sherbrooke’s tech company accelerator (ACET), an incubator designed to guide software development among start-up companies, to enable them to achieve growth, by, for example, helping to secure financing.

A tried and tested product

Thanks to their various partners who believe in the quality of their innovative products, LUMED’s current team of nine is likely to grow over the next 18 months.

On the day of our interview, the company announced an international alliance with bioMérieux, an in vitro diagnostics specialist. The challenge for LUMED will be to bridge all the data produced by bioMérieux with the patient’s bedside care. “If new information on the patient’s context requires a treatment adjustment, our system generates alerts that advise clinicians to respond based on the newly available information,” explains Vincent.

“For us, this partnership highlights the fact that the world leader in microbiology diagnostics looked at all the competing software from around the world and determined that our technology was the most effective in meeting the needs of clinicians,” the co-founder proudly asserts. Accordingly, LUMED’s chances of penetrating numerous markets in Europe and North America are greatly increased.

It’s no wonder that their technology is gaining ground on the international scene: its long-term use has been shown to produce sustained savings of $350,000 per year in drug purchases (representing about 30% of a hospital’s antibiotics budget), in addition to the drastic cost reduction associated with shortened lengths of stay. In addition, the overall decrease of 20% in antibiotic consumption helps to minimize the emergence of resistant bacteria.

Innovating every day…

The Centre hospitalier universitaire de Sherbrooke is a major partner of LUMED, who collaborates with its research centre on an ongoing basis. The company is currently involved in a number of new projects, such as a drug management platform for intensive care, oncology research and infection prevention.

With a broad range of applications for its technology, LUMED’s biggest challenge is to convince hospital IT teams to collaborate on the implementation of its solution. “It’s not something you can put on a CD and give to a pharmacist to install on their computer,” indicates Vincent. “It’s a sizeable implementation and our challenge is to get the IT teams on board. The benefits of this technology aren’t necessarily obvious to them because they’re not the ones who will be using it. So we need to find the right people to lead the project internally and get the support we need to make it a success.”

With its growing reputation in Quebec and around the world, LUMED will surely be able to overcome this kind of obstacle!

Source: Mélanie Pilon, writer for the Vitrine Star Tech

Be a part of technopolys!

25Apr 2018

The secret of our success? Our people, no doubt. A company can’t achieve excellence in process and technology without people. So, the team is our most important asset… the intelligence and culture of our team.
– Andy Kulakowski, President and CEO of Fresche

Fresche is the world’s largest modernization and management company for applications in the IBM i (formerly AS400) market. With 22,000 existing clients and 130,000 potential clients to acquire in this 30-year-old market, Fresche demonstrates that their solutions, technologies and skills allow them to meet the current needs of the sector.

Continue reading

18Apr 2018

Before the web existed, we worked a lot in schools and were motivated to offer content in digital form, specifically francophone and Quebecois content, because what existed at the time was mainly in English. Today, we have several anglophone partners, but we have nevertheless realized that our great strength lies in multilingual content, since other territories and languages share our concerns.
– Marc Boutet, President, CEO – De Marque

With their integrated offering for digital distribution, including services such as marketing and quick access to an online store, De Marque enables publishers to distribute and sell their content to a variety of audiences locally, nationally and internationally. Producers of digital books and web content can do business directly with retailers such as Renaud-Bray and Amazon, or take advantage of the De Marque network, which simultaneously reaches 2,300 points of sale and 2,000 libraries.

Continue reading

11Apr 2018

When finishing my Masters in Management, I was faced with the classic ‘what-do-I-do-now?’ dilemma. Applying for a job didn’t feel right to me, so I followed the wise advice of my teacher, who reminded me that I didn’t necessarily need to have experience before going into business: ‘If that’s what you want to do, go for it, Amira!
– Amira Boutouchent, Co-founder and CEO of Bridgr

Bridgr supports manufacturing SMEs in their digital transformation, offering a virtual hub where companies can identify and collaborate with the key tech experts and providers necessary to make the change happen.

This Quebec startup matches technologies and specialists with clients, according to their needs, both in terms of expertise and corporate culture. Client companies make a selection from three to six profiles and use a platform specifically designed by Bridgr for the management of manufacturing projects, including everything from the documents related to these suppliers to payment of their services.

Continue reading